Sangamo Therapeutics
SGMO
#10618
Rank
S$39.25 M
Marketcap
S$0.09475
Share price
0.00%
Change (1 day)
-89.09%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2026 (TTM): -S$0.15 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are S$34.55 Million. In 2025 the company made an earning of -S$0.14 Billion a decrease over its 2024 earnings that were of -S$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$0.15 Billion2.43%
2025 -S$0.14 Billion9.71%
2024 -S$0.13 Billion-17.27%
2023 -S$0.16 Billion-40.88%
2022 -S$0.26 Billion9.79%
2021 -S$0.24 Billion41.52%
2020 -S$0.17 Billion23.17%
2019 -S$0.14 Billion36.33%
2018 -S$98.79 Million36.89%
2017 -S$72.17 Million-22.32%
2016 -S$92.91 Million54.86%
2015 -S$60 Million75.62%
2014 -S$34.17 Million0.13%
2013 -S$34.12 Million
2011 -S$45.87 Million43.66%
2010 -S$31.93 Million28.52%
2009 -S$24.85 Million-23.55%
2008 -S$32.5 Million2.45%
2007 -S$31.72 Million19.5%
2006 -S$26.55 Million50.78%
2005 -S$17.61 Million75%
2004 -S$10.06 Million-33.25%
2003 -S$15.07 Million-62.27%
2002 -S$39.95 Million102.82%
2001 -S$19.7 Million23.21%
2000 -S$15.99 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.55 B-23,855.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$13.17 B-9,424.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$1.29 B-1,016.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-S$1.28 Billion 803.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-S$2.51 Billion 1,672.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$9.84 B-7,070.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$1.43 B-1,119.42%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$0.19 B-235.16%๐Ÿ‡บ๐Ÿ‡ธ USA